ClinVar Miner

Submissions for variant NM_152263.4(TPM3):c.118-12G>A

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
The Morris Kahn Laboratory of Human Genetics, Ben-Gurion University of the Negev RCV002285529 SCV002318976 pathogenic Congenital myopathy with fiber type disproportion 2022-03-29 criteria provided, single submitter research
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV002285529 SCV003922341 likely pathogenic Congenital myopathy with fiber type disproportion 2023-05-02 criteria provided, single submitter curation The homozygous c.118-12G>A variant in TPM3 was identified by our study in one individual with autosomal recessive congenital fiber-type disproportion myopathy. The c.118-12G>A variant in TPM3 has been reported in one individual with autosomal recessive congenital fiber-type disproportion myopathy, who was homozygous for the variant (PMID: 35796944). This variant has also been reported in ClinVar (Variation ID: 1526419) and has been interpreted as pathogenic by the Morris Kahn Laboratory of Human Genetics,Ben-Gurion University of the Negev. This variant is absent in population databases. RT-PCR and qPCR analysis of patient skeletal muscle tissue showed 97% reduction of the TPM3.12 isoform, the isoform of TPM3 most highly expressed and specific to skeletal muscle, versus control sample (PMID: 35796944). This variant is located in the 3’ splice region. Computational tools do suggest an impact to splicing. However, this information is not predictive enough to determine pathogenicity. There is an in-frame cryptic splice site 12 bases from the intron-exon boundary, providing evidence that this variant may delete 41 amino acids instead of causing loss of function. However, this information is not predictive enough to determine pathogenicity. Loss of function of the TPM3 gene is an established disease mechanism in autosomal recessive autosomal recessive congenital fiber-type disproportion myopathy. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive congenital fiber-type disproportion myopathy. ACMG/AMP Criteria applied: PS3, PM2_Supporting, PM3 (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.